Stock Analysis
- United Kingdom
- /
- Healthcare Services
- /
- LSE:IDHC
Integrated Diagnostics Holdings Third Quarter 2023 Earnings: EPS: ج.م0.30 (vs ج.م0.03 loss in 3Q 2022)
Integrated Diagnostics Holdings (LON:IDHC) Third Quarter 2023 Results
Key Financial Results
- Revenue: ج.م1.18b (up 40% from 3Q 2022).
- Net income: ج.م177.8m (up from ج.م18.2m loss in 3Q 2022).
- Profit margin: 15% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue.
- EPS: ج.م0.30 (up from ج.م0.03 loss in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Integrated Diagnostics Holdings Earnings Insights
Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Healthcare industry in the United Kingdom.
Performance of the British Healthcare industry.
The company's shares are up 8.8% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 1 warning sign for Integrated Diagnostics Holdings that you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Integrated Diagnostics Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About LSE:IDHC
Integrated Diagnostics Holdings
A consumer healthcare company, provides various medical diagnostics services to patients.
Flawless balance sheet and undervalued.